February 2025 Price Concessions 2nd Update

THIS CONTENT HAS NOW EXPIRED

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (18/02/2025) announced the following list of price concessions for February 2025:

Drug Pack size Price concession
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops 3 £8.83
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% gel 60 £23.70
Cefalexin 500mg tablets 21 £2.85
Clarithromycin 125mg/5ml oral suspension 70 £5.79
Estradiol 10microgram pessaries 24 £10.68
Fenofibrate micronised 160mg tablets 28 £3.50
Gabapentin 600mg tablets 100 £46.60
Hydroxocobalamin 1mg/1ml solution for injection ampoules 5 £11.02
Isosorbide mononitrate 20mg tablets 56 £3.85
Isotretinoin 20mg capsules 30 £13.67
Lactulose 3.1-3.7g/5ml oral solution 500 £5.15
Latanoprost 50micrograms/ml eye drops 2.5 £1.92
Methylphenidate 10mg tablets 30 £4.13
Methylphenidate 54mg modified-release tablets 30 £73.62
Mometasone 0.1% ointment 30 £3.13
Naftidrofuryl 100mg capsules 84 £10.90
Ondansetron 8mg tablets 10 £4.19
Pregabalin 100mg capsules 84 £2.29
Ramipril 2.5mg tablets 28 £1.19
Salbutamol 100micrograms/dose inhaler CFC free 200 £1.97
Travoprost 40micrograms/ml / timolol 5mg/ml eye drops 2.5 £12.51
Venlafaxine 225mg modified-release capsules 28 £20.71
Verapamil 80mg tablets 84 £2.30

For the full list of price concessions granted for February 2025 so far please visit our price concession hub page here.

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website (cpe.org.uk/priceconcessions) Please see our latest funding and reimbursement short videos for further information on the recent changes to the price concession process.